Seeing the light


The article 'Making Light Work' (Chemistry World, April 2012, p52) coincided with an alarming Daily Telegraph article relating the near-catastrophic increase in antibiotic resistance due to misuse by the NHS and in agriculture. It seems that big pharma is no longer interested in infection control for two reasons:

1 Any new antibiotic will quickly become ineffective due to acquired resistance.

2 They can make more money with continuous-use drugs to treat obesity, cholesterol and blood pressure than they can make on a 10-day course of antibiotics.

It is no great surprise that they are not interested in the potential of photodynamic therapy (PDT). The argument that they are not engineers is very negative, as in other fields of chemistry, such as cleaning and disinfection of food manufacturing equipment, it is routine for the chemical company to supply and service the dispensing equipment.

PDT is too good an opportunity to waste and there is a moral case for its commercialisation. I wonder if the experts in PDT would consider forming a cooperative organisation whereby professional scientists bought small shareholdings in the venture. I for one would be very happy to contribute a modest percentage of my pension.

M Barrett MRSC
Tewkesbury, UK


Related Content

Chemistry World podcast - October 2013

2 October 2013 Podcast | Monthly

news image

Chemists are helping palaeontologists discover the palette of fossil pigments, and helping toxicologists design greener compo...

Chemistry World podcast - February 2013

4 February 2013 Podcast | Monthly

news image

Graham Richards discusses crowdsourcing, Eric Wolff talks about ice cores and the team cover the latest chemical news

Most Read

Better batteries with pure lithium anodes

28 July 2014 Research

news image

Protective carbon nanosphere coating overcomes lithium problems, pointing the way to improved capacity

Takeover battle pushes Allergan to cut R&D jobs

28 July 2014 Business

news image

Besieged by serially acquisitive Valeant, the Botox maker will lay off 1500 staff to propel earnings growth

Most Commented

Bubble wrap could send lab costs packing

23 July 2014 Research

news image

Potential bubbles up across wide range of uses as storage and test vessels, especially for poor countries

Relativity behind mercury's liquidity

21 June 2013 Research

news image

First evidence that relativistic effects are indeed responsible for mercury's low melting point